SEARCH

SEARCH BY CITATION

References

  • 1
    Nachman RL, Polley M: The platelet as an inflammatory cell, Advances in Inflammation Research. Vol. I. Edited by G. Weissmann, BSamuelson, RPaoletti. New York, Raven Press, 1979, pp 169173
  • 2
    Weiss HJ: Platelet physiology and abnormalities of platelet function. N Engl J Med 293: 531591, 1975
  • 3
    MacIntyre DE: The platelet release reaction, Platelets in Biology and Pathology. Edited by JLGordon. Research Monographs in Cell and Tissue Physiology. Vol. 1. New York, Elsevier North-Holland Publishing Company, 1976, pp 6185
  • 4
    Day HJ, Holmsen H: Concepts to the blood platelet release reaction. Ser Haematol 4 (1): 327, 1971
  • 5
    Ginsberg MH, O'Malley M: Serum factors releasing serotonin from normal platelets. Ann Intern Med 87: 564567, 1977
  • 6
    Weissbarth E, Liman W, Eckert G, Menninger H, Deicher H: A platelet release inducing immunoglobulin in serum and synovia from patients with rheumatoid arthritis and systemic lupus erythematosus, Arthritis: Models and Mechanisms. Edited by HDeicher, LCISchulz. Heidelberg, Springer-Verlag, 1981, pp 244248
  • 7
    Weissbarth E, Baruth B, Mielke H, Liman W, Deicher H: Platelets as target cells in rheumatoid arthritis and systemic lupus erythematosus: a platelet specific immunoglobulin inducing the release reaction. Rheumatol Int 2: 6773, 1982
  • 8
    Fink PC, Piening U, Fricke M, Deicher H: Platelet aggregation and platelet inhibition by different antiglobulin complexes from sera of patients with rheumatoid arthritis. Arthritis Rheum 22: 896903, 1979
  • 9
    Henson PM, Spiegelberg HL: Release of serotonin from human platelets induced by aggregated immunoglobulins of different classes and subclasses. J Clin Invest 52: 12821288, 1973
  • 10
    Yeatts RP, Turner R, Collins R, Kaufmann J, Mashburn H: Soluble and insoluble immune complex-platelet interactions in rheumatoid inflammation. Ann Rheum Dis 37: 421427, 1978
  • 11
    Valone FH, Austen KF, Goetzl EJ: Identification of the platelet activating activity in rheumatoid synovial fluid as an intermediate molecular weight complex of IgG. J Immunol 122: 703709, 1979
  • 12
    Shapleigh C, Valone FH, Schur PH, Goetzl EJ, Austen KF: Platelet-activating activity in synovial fluids of patients with rheumatoid arthritis, juvenile rheumatoid arthritis, gout, and noninflammatory arthropathies. Arthritis Rheum 23: 800807, 1980
  • 13
    Mustard JF, Morat JF, MacMorine HZ, Senyi A: Release of permeability factors from blood platelets. Proc Soc Exp Biol Med 119: 988991, 1965
  • 14
    Nachman RL, Weksler B, Ferris B: Characterization of human platelet vascular permeability-enhancing activity. J Clin Invest 51: 549556, 1972
  • 15
    Benveniste J, Mencia-Huerta JM, Camussi G: Immune mechanisms of immune complex deposition, Advances in Inflammation Research. Vol. I. Edited by GWeissmann, BSamuelson, RPaoletti. New York, Raven Press, 1979, pp 353358
  • 16
    Kniker WT, Cochrane CG: The localisation of circulating immune complexes in experimental serum sickness: the role of vasoactive amines and hydrodynamic factors. J Exp Med 127: 119136, 1968
  • 17
    Clark WF, Lewis ML, Cameron JS, Parsons V: Intrarenal platelet consumption in the diffuse proliferative glomerulonephritis of systemic lupus erythematosus. Clin Sci Mol Med 49: 247252, 1975
  • 18
    Parbtani A, Cameron JS: Platelet and plasma serotonin concentration in glomerulonephritis. Thromb Res 15: 109125, 1975
  • 19
    Budman DR, Steinberg AD: Hematologic aspects of systemic lupus erythematosus. Ann Intern Med 86: 202229, 1977
  • 20
    Hutchinson R, Davis P, Jayson M: Thrombocytosis in rheumatoid arthritis. Ann Rheum Dis 35: 138142, 1976
  • 21
    Meyerhoff J, Dorsch CA: Decreased platelet serotonin levels in systemic lupus erythematosus. Arthritis Rheum 24: 14951500, 1981
  • 22
    Smith A, Castor W: Platelet abnormalities in patients with rheumatoid arthritis. J Rheumatol 5: 177183, 1978
  • 23
    Weiss H, Rosove M, Lages B, Kaplan K: Acquired storage pool deficiency with increased platelet-associated IgG. Am J Med 69: 711717, 1980
  • 24
    Zahavi J, Marder VJ: Acquired “storage pool disease” of platelets associated with circulating antiplatelet antibodies. Am J Med 56: 883890, 1974
  • 25
    Drummond AH, Gordon JL: Rapid, sensitive method for platelet 5HT. Thromb Diathes Haemorrh 31: 366367, 1974
  • 26
    Komesu NN, Thompson JH: Optimum concentration of OPT for the fluorometric measurement of serotonin. Eur J Pharmacol 16: 248250, 1971
  • 27
    Thompson JH, Spezia ChA, Angulo M: Fluorometric detection of serotonin using OPT: an improvement. Experientia 26: 327329, 1970
  • 28
    Weissbarth E, Sedlacek HH, Seiler FR, Fricke M, Deicher H: Release of 3H-serotonin and endogenous β-thromboglobulin from human platelets by immune complexes. Behring Inst Mitt 64: 121126, 1979
  • 29
    Zubler RH, Lambert PH: The 125I-Clq binding test for the detection of soluble immune complexes, In Vitro Methods in Cell Mediated and Tumor Immunity. Edited by BBloom, JDavid. New York, Academic Press, 1976, pp 565572
  • 30
    American Rheumatism Association Committee on Diagnostic and Therapeutic Criteria, Progress Report, Annual Meeting 1962, Arthritis and Allied Conditions. Seventh edition. Edited by JLHollander. Philadelphia, Lea & Febiger, 1966, p 288
  • 31
    Kaben G, Klein S, Menninger H, Peter HH: Verlaufsbeobachtungen bei SLE und MCTD (unpublished)
  • 32
    Kalden JR, Zimmer I, Deicher H: Die Bedeutung von Serum-Antikörpern gegen ds-DNS für die Diagnostik und klinischen Verlauf von Patienten mit einem sytemischen Lupus erythematodes. Inn Med 3: 512, 1976
  • 33
    Selroos O: Thrombocytosis in rheumatoid arthritis. Scand J Rheumatol 1: 136140, 1972
  • 34
    Hryszko S, Bogdanikowa B: Incidence and pathomechanism of thrombocytosis in rheumatoid arthritis. Rheumatologia 13: 151155, 1975
  • 35
    Valentini G, Chianese U, Tirri G, Giordano M: Thrombocytosis as an inflammation index in rheumatic and connective tissue diseases, Advances in Inflammation Research. Edited by GWeissmann, BSamuelson, RPaoletti. New York, Raven Press, 1979, pp 579584
  • 36
    Endresen G, Hoyeraal H, Kass E: Platelet count and disease activity in juvenile rheumatoid arthritis. Scand J Rheumatol 6: 237240, 1977
  • 37
    Karpatkin S: Heterogeneity of human platelets. I. Metabolic and kinetic evidence suggestive of young and old platelets. J Clin Invest 48: 10731082, 1969
  • 38
    Cines DB, Schreiber AD: Immune thrombocytopenia. N Engl J Med 300: 106111, 1979
  • 39
    Camussi G, Mencia-Huerta JM, Benveniste J: Release of platelet activating factor and histamine. I. Effect of immune complexes, complement and neutrophils on human and rabbit mastocytes and basophils. Immunology 33: 523534, 1977
  • 40
    Vargaftig BB, Chignard M, Benveniste J: Present concepts on the mechanism of platelet aggregation. Biochem Pharmakol 30: 263271, 1981
  • 41
    Bennett RM, Eddie-Quartey AC, Holt PJL: Fibrin degradation products in rheumatoid arthritis. Ann Rheum Dis 31: 372388, 1972
  • 42
    Conn DL, McDuffie FC, Kazmier FJ, Schroeter AL, Sun NCJ: Coagulation abnormalities in rheumatoid disease. Arthritis Rheum 19: 12371243, 1976
  • 43
    Cameron JS: Platelets and glomerulonephritis. Nephron 18: 253258, 1977
  • 44
    Ginsberg MH, O'Malley M: Serum factors releasing serotonin from normal platelets: relation of the manifestation of systemic lupus erythematosus. Ann Intern Med 87: 564567, 1977
  • 45
    Weiss HJ, Witte LD, Kaplan KL, Lages BA, Chernoll A, Nossel HL, Goodman DS, Baumgartner HR: Heterogeneity in storage pool deficiency: studies on granulebound substances in 18 patients including variants deficient in α-granules, platelet factor 4, β-thromboglobulin, and platelet-derived growth factor. Blood 54: 12961319, 1979
  • 46
    Nydegger UE, Lambert PH, Gerber H, Miescher PA: Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. J Clin Invest 54: 297309, 1974
  • 47
    Gupta RC, McDuffie FC, Huston KA, Tappeiner G, Meurer M, Jordon RE, Luthra HS, Hunder GG, Ilstrup D: Comparison of three immunoassays for immune complexes in rheumatoid arthritis. Arthritis Rheum 22: 433439, 1979
  • 48
    Halla JT, Volonakis JE, Schrohenloher RE: Immune complexes in rheumatoid arthritis sera and synovial fluids. Arthritis Rheum 22: 440448, 1979
  • 49
    Liman W, Heinrichs K, Witttenborg A, Fricke M, Baruth B, Deicher H: Value of different immune complex assays in the course of rheumatoid arthritis, Arthritis: Models and Mechanisms. Edited by HDeicher, LCISchulz. Heidelberg, Springer-Verlag, 1981, pp 239243
  • 50
    Harker LA, Slichter SJ: Platelet and fribrinogen consumption in man. N Engl J Med 287: 9991006, 1972
  • 51
    George CRP, Slichter SJ, Quadracci LJ, Striker GE, Harker LA: A kinetic evaluation of haemostatis in renal disease. N Engl J Med 291: 11111115, 1974
  • 52
    Sergent JS, Sherman RL, Al-Mondhiry H: Fibrinogen catabolism in systemic lupus erythematosus. Arthritis Rheum 19: 195198, 1976
  • 53
    Hardin JA, Cronlund M, Haber E, Bloch KJ: Activation of blood clotting in patients with systemic lupus erythematosus. Am J Med 65: 430436, 1978
  • 54
    Kaplan KL, Brockman MJ, Chernoff A, Usznik GR, Drillings M: Platelet α-granule proteins: studies on release and subcellular localization. Blood 53: 604618, 1979
  • 55
    Krapf F, Renger D, Schedel I, Leiendecker K, Leyssens H, Deicher H: A PEG-precipitation laser nephelometer technique (PPLaNT) for the detection and characterization of circulating immune complexes in human sera. J Immunol Methods 54: 107117, 1982